The national cancer screening program for breast cancer in the Republic of Korea: Is it cost-effective?

Moon Hae Kang, Eun Cheol Park, Kui Son Choi, MiNa Suh, Jae Kwan Jun, Eun Cho

    Research output: Contribution to journalArticle

    17 Scopus citations

    Abstract

    This goal of this research was to evaluate the cost-effectiveness of the National Cancer Screening Program (NCSP) for breast cancer in the Republic of Korea from a government expenditure perspective. In 2002-2003 (baseline), a total of 8,724,860 women aged 40 years or over were invited to attend breast cancer screening by the NCSP. Those who attended were identified using the NCSP database, and women were divided into two groups, women who attended screening at baseline (screened group) and those who did not (non-screened group). Breast cancer diagnosis in both groups at baseline, and during 5-yearfollow-up was identified using the Korean Central Cancer Registry. The effectiveness of the NCSP for breast cancer was estimated by comparing 5-year survival and life years saved (LYS) between the screened and the unscreened groups, measured using mortality data from the Korean National Health Insurance Corporation and the National Health Statistical Office. Direct screening costs, indirect screening costs, and productivity costs were considered in different combinations in the model. When all three of these costs were considered together, the incremental cost to save one life year of a breast cancer patient was 42,305,000 Korean Won (KW) (1 USD=1,088 KW) for the screened group compared to the non-screened group. In sensitivity analyses, reducing the false-positive rate of the screening program by half was the most cost-effective (incrementalcost-effectiveness ratio, ICER=30,110,852 KW/LYS) strategy. When the upper age limit for screening was set at 70 years, itbecame more cost-effective (ICER=39,641,823 KW/LYS) than when no upper age limit was set. The NCSP for breast cancer in Korea seems to be accepted as cost-effective as ICER estimates were around the Gross Domestic Product. However, cost-effectiveness could be further improved by increasing the sensitivity of breast cancer screening and by setting appropriate age limits.

    Original languageEnglish (US)
    Pages (from-to)2059-2065
    Number of pages7
    JournalAsian Pacific Journal of Cancer Prevention
    Volume14
    Issue number3
    DOIs
    StatePublished - 2013

    Keywords

    • Breast cancer screening
    • Cost-effectiveness analysis
    • Economic evaluation
    • Korea
    • Mammography

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research
    • Public Health, Environmental and Occupational Health
    • Epidemiology

    Fingerprint Dive into the research topics of 'The national cancer screening program for breast cancer in the Republic of Korea: Is it cost-effective?'. Together they form a unique fingerprint.

  • Cite this